Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
Cell therapy is also known as cellular therapy or cytotherapy is a therapy in which cellular material is injected into a patient; this generally means intact, living cells. For instance, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance
Cell therapy was originated in the nineteenth century when scientists tested by injecting animal material in an attempt to prevent and treat illness. Though such efforts produced no positive benefit, further research establish in the mid twentieth century that human cells could be used to help prevent the human body rejecting transplanted organs, leading in time to successful bone marrow transplantation.
Today two distinct categories of cell therapy are recognized.
The first category is cell therapy in mainstream medicine. It is the method of intense research and the basis of potential therapeutic benefit. Such research can be controversial when it involves human embryonic material.
The second category is in alternative medicine, and continues the practice of injecting animal materials in an attempt to cure disease. This practice, according to the American Cancer Society, is not backed by any medical evidence of effectiveness, and can have deadly consequences.
The global stem cell therapy market is expected to reach $330 million by 2020, at a CAGR of 39.5% from 2015 to 2020. The global stem cell market in 2015is expected to be dominated by North America, followed by Asia-Pacific and Europe. However, Asia-Pacific market is expected to surpass North America by 2020, owing to the high number of ongoing research activities.
International Symposium and Workshops
1. Phacilitate: 11th Annual Cell & Gene Therapy Forum, January 26-28, 2015 Washington DC, USA
2. Cell & Gene Therapy Europe, September 29-30, 2015 Barcelona, Spain
3. Cell Therapy Manufacturing & Gene Therapy Congress, December 2-3, 2015 Brussels, Belgium
Relevant Society and Associations
This page will be updated regularly.
This page was last updated on January 17, 2020